Paper3922223
The clinical spectrum of alpha-L-iduronidase deficiency.
Roubicek M and 2 others. Am J Med Genet, 1985. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. The clinical spectrum of alpha-L-iduronidase deficiency. Papers, record 3922223. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3922223
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glycoside Hydrolases | Major topic |
| Iduronidase | Major topic |
| Mucopolysaccharidoses | Major topic |
| Mucopolysaccharidosis I | Major topic |
| Adolescent | |
| Child | |
| Child, Preschool | |
| Female | |
| Humans | |
| Infant | |
| Male | |
| Phenotype |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32154058 | Development of a newborn screening tool for mucopolysaccharidosis type I based on bivariate normal limits: Using glycosaminoglycan and alpha-L-iduronidase determinations on dried blood spots to predict symptoms. | JIMD Rep | 2020 | https://conductscience.org/library/papers/32154058 | PubMed |
| 26052536 | A novel, long-lived, and highly engraftable immunodeficient mouse model of mucopolysaccharidosis type I. | Mol Ther Methods Clin Dev | 2015 | https://conductscience.org/library/papers/26052536 | PubMed |
| 25922936 | Ultrasonographic Features of Hip Joints in Mucopolysaccharidoses Type I and II. | PLoS One | 2015 | https://conductscience.org/library/papers/25922936 | PubMed |
| 25410665 | Growth patterns in children with mucopolysaccharidosis I and II. | World J Pediatr | 2015 | https://conductscience.org/library/papers/25410665 | PubMed |
| 24088413 | Treatment of hip dysplasia in patients with mucopolysaccharidosis type I after hematopoietic stem cell transplantation: results of an international consensus procedure. | Orphanet J Rare Dis | 2013 | https://conductscience.org/library/papers/24088413 | PubMed |
| 24036510 | Insights into mucopolysaccharidosis I from the structure and action of α-L-iduronidase. | Nat Chem Biol | 2013 | https://conductscience.org/library/papers/24036510 | PubMed |
| 23837464 | An algorithm to predict phenotypic severity in mucopolysaccharidosis type I in the first month of life. | Orphanet J Rare Dis | 2013 | https://conductscience.org/library/papers/23837464 | PubMed |
| 19707455 | alpha-L-iduronidase therapy for mucopolysaccharidosis type I. | Biologics | 2008 | https://conductscience.org/library/papers/19707455 | PubMed |
| 15882450 | Atypical microbial infections of digestive tract may contribute to diarrhea in mucopolysaccharidosis patients: a MPS I case study. | BMC Pediatr | 2005 | https://conductscience.org/library/papers/15882450 | PubMed |
| 10702409 | Impaired elastogenesis in Hurler disease: dermatan sulfate accumulation linked to deficiency in elastin-binding protein and elastic fiber assembly. | Am J Pathol | 2000 | https://conductscience.org/library/papers/10702409 | PubMed |
| 1950476 | Bone marrow transplant in a case of mucopolysaccharidosis I Scheie phenotype: skin ultrastructure before and after transplantation. | Acta Neuropathol | 1991 | https://conductscience.org/library/papers/1950476 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3922223
GET https://conductscience.org/api/papers/v1/3922223/authors